Jonathan Barrett MacKenzie's Insider Trades & SAST Disclosures
Jonathan Barrett MacKenzie's most recent trade in Medifast Inc was a trade of 280 Common Stock done at an average price of $13.9 . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Jonathan Barrett MacKenzie.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 13 Mar 2025 | 280 | 3,626 (0%) | 0% | 13.9 | 3,884 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 13 Mar 2025 | 99 | 3,467 (0%) | 0% | 14.4 | 1,421 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.93 per share. | 13 Mar 2025 | 60 | 3,566 (0%) | 0% | 13.9 | 836 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.91 per share. | 13 Sep 2024 | 11 | 3,906 (0%) | 0% | 18.9 | 208 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 83 | 3,917 (0%) | 0% | 36.6 | 3,039 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 51 | 4,000 (0%) | 0% | 36.6 | 1,867 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 2,565 | 4,051 (0%) | 0% | 0 | Common Stock | |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.10 per share. | 13 Sep 2023 | 10 | 1,486 (0%) | 0% | 81.1 | 811 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 906 | 1,496 (0%) | 0% | 0 | Common Stock | |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.46 per share. | 16 Mar 2023 | 57 | 590 (0%) | 0% | 104.5 | 5,954 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.60 per share. | 13 Sep 2022 | 10 | 647 (0%) | 0% | 124.6 | 1,246 | Common Stock |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 548 | 657 (0%) | 0% | 0 | Common Stock | |
|
Medifast Inc
|
Jonathan Barrett MacKenzie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2021 | 109 | 109 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges